HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis

Rheumatol Int. 2006 Feb;26(4):285-7. doi: 10.1007/s00296-005-0614-x. Epub 2005 Jul 20.

Abstract

The aim of this study was to determine the distribution of human leukocyte antigen (HLA)-B27 subtypes in serologically HLA-B27-positive ankylosing spondylitis (AS) patients and healthy controls from the Turkish population and to compare this with other reports from other populations. We subtyped HLA-B27 in 38 HLA-B27-positive Turkish patients with AS and 47 HLA-B27-positive healthy controls without AS by polymerase chain reaction with specific sequence primers (PCR-SSP). The results demonstrated that: B*2705 was the predominant subtype among both of the patients (71.1%) and controls (68.0%). B*2702 was observed in 26.3% and 32.0% of the patients and controls, respectively. B*2708 subtype was found in 2.6% of the patients but not among the control group. When the distribution of B27 subtypes in Turkish populations was compared with that in other populations, similar frequencies with the Caucasian-Europe groups were noted. However, this should be interpreted carefully because of the small number of individuals in our study.

MeSH terms

  • Adolescent
  • Adult
  • Alleles
  • Female
  • Genetic Predisposition to Disease*
  • HLA-B27 Antigen / genetics*
  • HLA-B27 Antigen / immunology
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Spondylitis, Ankylosing / genetics*
  • Spondylitis, Ankylosing / immunology
  • Turkey

Substances

  • HLA-B27 Antigen